Some recent studies of GIST and chondrosarcoma have shown a correlation between the expression of angiogenic markers, such as VEGF and microvessel density, and a worse prognosis [33, 34], suggesting that the development of antiangiogenic chemotherapy might be useful. The gene discussed is VEGFA; the disease is chondrosarcoma.